HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors.

Abstract
Placental ATP binding cassette (ABC) transporters protect placental and fetal tissues by effluxing xenobiotics and endogenous metabolites. We have investigated the effects of cytokines and survival/growth factors, implicated in various placental pathologies, on ABC transporter expression and function in primary placental trophoblast cells. Treatment of primary term trophoblasts in vitro with tumor necrosis factor-alpha (TNF-alpha) or interleukin (IL)-1beta decreased mRNA and protein expression of apical transporters ABCB1/multidrug resistance gene product 1 (MDR1) and ABCG2/breast cancer resistance protein (BCRP) protein by 40 to 50% (P < 0.05). In contrast, IL-6 increased mRNA and protein expression of the basolateral transporter ABCB4/MDR3 (P < 0.05), whereas ABCC1/MRP1 expression was unaltered. Pretreatment of trophoblasts with TNF-alpha over 48 h resulted in significantly decreased BCRP efflux activity (increased mitoxantrone accumulation) with minimal changes in MDR1/3 activity. Epidermal growth factor (EGF) and insulin-like growth factor II, on the other hand, significantly increased BCRP expression at the mRNA and protein level (P < 0.05); EGF treatment also increased BCRP functional activity. Estradiol stimulated BCRP, MDR1, and MDR3 mRNA and protein expression by 40 to 60% and increased MDR1/3 functional activity (P < 0.05). Progesterone had modest positive effects on MRP1 mRNA and MDR1 protein expression (P < 0.05). In conclusion, this study shows that proinflammatory cytokines, sex steroids, and growth factors exert independent effects on expression of apical and basolateral placental ABC transporters in primary trophoblast. Such changes could alter placental drug disposition, increase fetal susceptibility to toxic xenobiotics, and impact on placental viability and function.
AuthorsDenis A Evseenko, James W Paxton, Jeffrey A Keelan
JournalDrug metabolism and disposition: the biological fate of chemicals (Drug Metab Dispos) Vol. 35 Issue 4 Pg. 595-601 (Apr 2007) ISSN: 0090-9556 [Print] United States
PMID17237156 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ATP-Binding Cassette Transporters
  • Cytokines
  • Gonadal Steroid Hormones
  • Intercellular Signaling Peptides and Proteins
  • Interleukin-1beta
  • Interleukin-6
  • Peptide Fragments
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • interleukin-1beta (163-171)
  • Progesterone
  • Estradiol
  • Epidermal Growth Factor
  • Insulin-Like Growth Factor II
  • Digoxin
  • Mitoxantrone
Topics
  • ATP-Binding Cassette Transporters (genetics, metabolism)
  • Cells, Cultured
  • Cytokines (metabolism, pharmacology)
  • Digoxin (metabolism)
  • Epidermal Growth Factor (metabolism)
  • Estradiol (metabolism)
  • Female
  • Gonadal Steroid Hormones (metabolism, pharmacology)
  • Humans
  • Insulin-Like Growth Factor II (metabolism)
  • Intercellular Signaling Peptides and Proteins (metabolism, pharmacology)
  • Interleukin-1beta (metabolism)
  • Interleukin-6 (metabolism)
  • Mitoxantrone (metabolism)
  • Peptide Fragments (metabolism)
  • Placenta (cytology, drug effects, metabolism)
  • Pregnancy
  • Progesterone (metabolism)
  • RNA, Messenger (metabolism)
  • Time Factors
  • Transcription, Genetic (drug effects)
  • Trophoblasts (drug effects, metabolism)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: